257 related articles for article (PubMed ID: 32341362)
1. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance.
Barbier V; Erbani J; Fiveash C; Davies JM; Tay J; Tallack MR; Lowe J; Magnani JL; Pattabiraman DR; Perkins AC; Lisle J; Rasko JEJ; Levesque JP; Winkler IG
Nat Commun; 2020 Apr; 11(1):2042. PubMed ID: 32341362
[TBL] [Abstract][Full Text] [Related]
2. Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?
Uy GL; DeAngelo DJ; Lozier JN; Fisher DM; Jonas BA; Magnani JL; Becker PS; Lazarus HM; Winkler IG
Blood Rev; 2024 May; 65():101184. PubMed ID: 38493006
[TBL] [Abstract][Full Text] [Related]
3. Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance.
Winkler IG; Barbier V; Nowlan B; Jacobsen RN; Forristal CE; Patton JT; Magnani JL; Lévesque JP
Nat Med; 2012 Nov; 18(11):1651-7. PubMed ID: 23086476
[TBL] [Abstract][Full Text] [Related]
4. Combining 5-azacitidine with the E-selectin antagonist uproleselan is an effective strategy to augment responses in myelodysplasia and acute myeloid leukaemia.
Enjeti AK; Fogler WE; Smith TAG; Lincz LF; Bond DR; Magnani JL
Br J Haematol; 2024 Jun; 204(6):2264-2274. PubMed ID: 38659295
[TBL] [Abstract][Full Text] [Related]
5. Targeting the microenvironment in acute myeloid leukemia.
Rashidi A; Uy GL
Curr Hematol Malig Rep; 2015 Jun; 10(2):126-31. PubMed ID: 25921388
[TBL] [Abstract][Full Text] [Related]
6. Acute Myeloid Leukemia Chemo-Resistance Is Mediated by E-selectin Receptor CD162 in Bone Marrow Niches.
Erbani J; Tay J; Barbier V; Levesque JP; Winkler IG
Front Cell Dev Biol; 2020; 8():668. PubMed ID: 32793603
[TBL] [Abstract][Full Text] [Related]
7. Expression and release of adhesion molecules by human acute myelogenous leukemia blasts.
Bruserud O; Ulvestad E
Leuk Res; 1999 Feb; 23(2):149-57. PubMed ID: 10071130
[TBL] [Abstract][Full Text] [Related]
8. RUNX transcription factors potentially control E-selectin expression in the bone marrow vascular niche in mice.
Morita K; Tokushige C; Maeda S; Kiyose H; Noura M; Iwai A; Yamada M; Kashiwazaki G; Taniguchi J; Bando T; Hirata M; Kataoka TR; Nakahata T; Adachi S; Sugiyama H; Kamikubo Y
Blood Adv; 2018 Mar; 2(5):509-515. PubMed ID: 29500219
[TBL] [Abstract][Full Text] [Related]
9. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
Wang A; Zhong H
Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
[TBL] [Abstract][Full Text] [Related]
11. Dissecting the role of the CXCL12/CXCR4 axis in acute myeloid leukaemia.
Ladikou EE; Chevassut T; Pepper CJ; Pepper AG
Br J Haematol; 2020 Jun; 189(5):815-825. PubMed ID: 32135579
[TBL] [Abstract][Full Text] [Related]
12. Adhesion to E-selectin promotes growth inhibition and apoptosis of human and murine hematopoietic progenitor cells independent of PSGL-1.
Winkler IG; Snapp KR; Simmons PJ; Lévesque JP
Blood; 2004 Mar; 103(5):1685-92. PubMed ID: 14592840
[TBL] [Abstract][Full Text] [Related]
13. E-selectin inhibition with GMI-1271 decreases venous thrombosis without profoundly affecting tail vein bleeding in a mouse model.
Culmer DL; Dunbar ML; Hawley AE; Sood S; Sigler RE; Henke PK; Wakefield TW; Magnani JL; Myers DD
Thromb Haemost; 2017 Jun; 117(6):1171-1181. PubMed ID: 28300869
[TBL] [Abstract][Full Text] [Related]
14. Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow.
Sanz-Ortega L; Andersson A; Carlsten M
Leukemia; 2024 Mar; 38(3):579-589. PubMed ID: 38182818
[TBL] [Abstract][Full Text] [Related]
15. Stromal CYR61 Confers Resistance to Mitoxantrone via Spleen Tyrosine Kinase Activation in Human Acute Myeloid Leukaemia.
Long X; Yu Y; Perlaky L; Man TK; Redell MS
Br J Haematol; 2015 Sep; 170(5):704-18. PubMed ID: 25974135
[TBL] [Abstract][Full Text] [Related]
16. E-selectin ligands recognised by HECA452 induce drug resistance in myeloma, which is overcome by the E-selectin antagonist, GMI-1271.
Natoni A; Smith TAG; Keane N; McEllistrim C; Connolly C; Jha A; Andrulis M; Ellert E; Raab MS; Glavey SV; Kirkham-McCarthy L; Kumar SK; Locatelli-Hoops SC; Oliva I; Fogler WE; Magnani JL; O'Dwyer ME
Leukemia; 2017 Dec; 31(12):2642-2651. PubMed ID: 28439107
[TBL] [Abstract][Full Text] [Related]
17. E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.
Dutta P; Hoyer FF; Sun Y; Iwamoto Y; Tricot B; Weissleder R; Magnani JL; Swirski FK; Nahrendorf M
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1802-8. PubMed ID: 27470513
[TBL] [Abstract][Full Text] [Related]
18. Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Pfister K; Nuessler V; Schmetzer H
Eur J Haematol; 2003 Nov; 71(5):366-76. PubMed ID: 14667200
[TBL] [Abstract][Full Text] [Related]
19. Shear stress-mediated adhesion of acute myeloid leukemia and KG-1 cells to endothelial cells involves functional P-selectin.
Bistrian R; Dorn A; Möbest DC; Rüster B; Ludwig R; Scheele J; Seifried E; Martin H; Henschler R
Stem Cells Dev; 2009 Oct; 18(8):1235-42. PubMed ID: 19105599
[TBL] [Abstract][Full Text] [Related]
20. The vascular bone marrow niche influences outcome in chronic myeloid leukemia
Godavarthy PS; Kumar R; Herkt SC; Pereira RS; Hayduk N; Weissenberger ES; Aggoune D; Manavski Y; Lucas T; Pan KT; Voutsinas JM; Wu Q; Müller MC; Saussele S; Oellerich T; Oehler VG; Lausen J; Krause DS
Haematologica; 2020 Jan; 105(1):136-147. PubMed ID: 31018977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
